Search Results

EVERSANA and MyHealthTeam today announced an alliance to help life sciences companies harness the power of Artificial Intelligence (AI) and accelerate the time to diagnosis and treatment for millions of patients across the globe.

Tonix Pharmaceuticals Holding Corp. announced today that EVERSANA® Life Science Services, LLC, a leading provider of commercialization services to the global life sciences industry, completed the initial phase of an assessment of the U.S market opportunity for TonmyaTM (also known as TNX-102 SL, cyclobenzaprine HCl sublingual tablets), a potential new first line therapy for the management of fibromyalgia.

Tonix Pharmaceuticals Holding Corp. announced today that EVERSANA®, a leading provider of commercialization services to the global life sciences industry, has been selected to support the launch strategy and commercial planning of Tonmya.

EVERSANA , a leading provider of commercial services to the global life sciences industry, today announced it has selected Adobe Firefly for Enterprise to transform its content supply chains with the power of generative AI.

Evoke Pharma, Inc. and EVERSANA announced a summary of real-world data on the positive impact of GIMOTI usage in reducing healthcare costs for patients suffering from diabetic gastroparesis versus patients taking oral metoclopramide.

Yaral Pharma Inc. today announced its expanding partnership with EVERSANA ® , a leading provider of commercialization services to the global life sciences industry, as its key commercialization partner to support the expansion of its portfolio of pain and endocrinology products in the U.S.

Evoke Pharma, Inc. EVERSANA™, a leading provider of global commercial services to the life science industry, announced that its abstract entitled “Nasal Metoclopramide Reduces Healthcare Visits in Diabetic Gastroparesis Patients With and Without Prior Oral Metoclopramide History” will be presented in a poster session at the American Neurogastroenterology and Motility Society (ANMS) Annual Meeting being held August 11-13, 2023 in Austin, Texas.